अमूर्त

Exploration of phytochemicals as active medicines against COVID-19 via molecular docking.

Okamu Chinore*

Molecular docking approaches were used to identify the best bioactive phytochemicals from several medicinal plants, indicating a possible pre-clinical drug discovery against SARS-CoV-2 viral infection. To compute binding affinity at SARS-active CoV-2's sites, researchers performed in silico screening of bioactive phytochemicals with the two druggable targets of the virus using basic precision/extra precision molecular docking methods. Scientists were forced to look for new antiviral treatments after the SARS-CoV-19 pandemics and the insufficiency of targeted medications. The current state of knowledge about plant extracts containing polyphenols that inhibit Covid-19 is presented. Natural phytochemicals originating from plants have the potential to establish coronavirus therapy and preventive research employing extracts and/or specific compounds. The polyphenolic medicines have the ability to block the coronavirus protein, which is required for virus infection and reproduction. After a thorough examination of isolated phytochemicals, the molecular descriptors, docking score, active sites, and FMOs energies were compared to those of commonly used COVID-19 medicines.